Patent details

EP3326643 Title: FACTOR VIII-FC CHIMERIC AND HYBRID POLYPEPTIDES, AND METHODS OF USE THEREOF

Basic Information

Publication number:
EP3326643
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP171946486
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
FACTOR VIII-FC CHIMERIC AND HYBRID POLYPEPTIDES, AND METHODS OF USE THEREOF
French Title of Invention:
POLYPEPTIDES CHIMÉRIQUES ET HYBRIDES DE FACTEUR VIII-FC ET LEURS PROCÉDÉS D'UTILISATION
German Title of Invention:
CHIMÄRE UND HYBRIDE FAKTOR-VIII-FC-POLYPEPTIDE UND VERFAHREN ZUR VERWENDUNG DAVON
SPC Number:

Dates

Filing date:
06/12/2010
Grant date:
07/04/2021
EP Publication Date:
30/05/2018
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/04/2021
EP B1 Publication Date:
07/04/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
06/12/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/03/2021
 
 

Name:
Bioverativ Therapeutics Inc.
Address:
225 Second Avenue, Waltham MA 02451, United States (US)

Agent

Name:
ARONOVA S.A.
From:
28/06/2021
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
NUGENT, Karen
Address:
United Kingdom (GB)

2

Name:
LUK, Alvin
Address:
United States (US)

3

Name:
MCKINNEY, Byron
Address:
United States (US)

4

Name:
OTTMER, Matt
Address:
United States (US)

5

Name:
PETERS, Robert
Address:
United States (US)

6

Name:
PIERCE, Glenn
Address:
United States (US)

7

Name:
JIANG, Haiyan
Address:
United States (US)

8

Name:
LOW, Susan
Address:
United States (US)

9

Name:
SOMMER, Jurg M.
Address:
United States (US)

10

Name:
LI, Lian
Address:
United States (US)

11

Name:
BITONTI, Alan, J.
Address:
United States (US)

12

Name:
DUMONT, Jennifer, A.
Address:
United States (US)

Priority

1

Priority Number:
267070 P
Priority Date:
06/12/2009
Priority Country:
United States (US)

2

Priority Number:
285054 P
Priority Date:
09/12/2009
Priority Country:
United States (US)

3

Priority Number:
301592 P
Priority Date:
04/02/2010
Priority Country:
United States (US)

4

Priority Number:
363065 P
Priority Date:
09/07/2010
Priority Country:
United States (US)

5

Priority Number:
373113 P
Priority Date:
12/08/2010
Priority Country:
United States (US)

6

Priority Number:
410929 P
Priority Date:
07/11/2010
Priority Country:
United States (US)

7

Priority Number:
419676 P
Priority Date:
03/12/2010
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/37; A61P 7/00; A61P 7/02; A61P 7/04; A61P 41/00; C07K 14/755; A61K 47/64; A61K 47/68;

Publication

European Patent Bulletin

1

Issue number:
202114
Publication date:
07/04/2021
Description:
Grant (B1)

2

Issue number:
202118
Publication date:
05/05/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
31/12/2025
Annual Fee Number:
16
Annual Fee Amount:
230 Euro
Expected Payer:
Last Annual Fee Payment Date:
28/11/2024
Last Annual Fee Paid Number:
15
Last Annual Fee Paid Amount:
213 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
28/06/2021 Outgoing Correspondence 1
25/06/2021 Power Of Attorney 1